Platelet-Activating Factor Regulates Cadherin-Catenin Adhesion System Expression and β-Catenin Phosphorylation during Kaposi's Sarcoma Cell Motility
- 31 May 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 166 (5) , 1515-1522
- https://doi.org/10.1016/s0002-9440(10)62367-x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expressionNature Cell Biology, 2000
- SMART: a web-based tool for the study of genetically mobile domainsNucleic Acids Research, 2000
- Motility Induced by Human Immunodeficiency Virus-1 Tat on Kaposi's Sarcoma Cells Requires Platelet-Activating Factor SynthesisThe American Journal of Pathology, 1999
- Cell Adhesion: The Molecular Basis of Tissue Architecture and MorphogenesisPublished by Elsevier ,1996
- Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasivenessBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- AIDS-associated Kaposiʼs sarcoma pathogenesis, clinical features, and treatmentCurrent Opinion in Oncology, 1993
- Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene.The Journal of cell biology, 1993
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991
- Presence of PAF-Acether in Human Breast Carcinoma: Relation to Axillary Lymph Node MetastasisJNCI Journal of the National Cancer Institute, 1989
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983